Oral HPV prevalence in HIV-positive and HIV-negative individuals
| Oral HPV prevalence | ||||||||
|---|---|---|---|---|---|---|---|---|
| HIV-positive | HIV-negative | |||||||
| Oral HPV infection | Women (N = 187), % | Men (N = 192), % | Total (N = 379), % | Women (N = 93), % | Men (N = 173), % | Total (N = 266), % | P, χ2 HIV+ vs. HIV− | Overall (N = 645), % |
| Any | 35 | 45 | 40 | 18 | 28 | 25 | <0.001 | 34 |
| Nononcogenic | 27 | 31 | 29 | 11 | 16 | 14 | <0.001 | 18 |
| Oncogenic | 18 | 23 | 21 | 8.6 | 17 | 14 | 0.033 | 23 |
| HPV 16 | 5.4 | 6.8 | 6.1 | 2.2 | 6.9 | 5.3 | 0.665 | 5.7 |
| Other oncogenic | 17 | 20 | 18 | 7.5 | 11 | 10 | 0.004 | 15 |
| Multiple concurrent | 18 | 19 | 19 | 7.5 | 6.4 | 6.8 | <0.001 | 14 |